Cardiotoxicity of combined pegylated liposomal doxorubicin and bevacizumab therapy: a propensity-matched cohort study and disproportionality analysis
Hoeger, Christopher W, Arrush Choudhary, Andrea Nathalie Rosas Diaz, Theresa Pinto, Sarah Smalec, Charles Doladille, Rishi K. Wadhera, et al. 2025. “Cardiotoxicity of Combined Pegylated Liposomal Doxorubicin and Bevacizumab Therapy: A Propensity-Matched Cohort Study and Disproportionality Analysis”. BMC Cardio-Oncology.